83 related articles for article (PubMed ID: 23262207)
1. HPV-type has no impact on survival of patients with adenocarcinoma of the uterine cervix.
Baalbergen A; Smedts F; Ewing P; Snijders PJ; Meijer CJ; Helmerhorst TJ
Gynecol Oncol; 2013 Mar; 128(3):530-4. PubMed ID: 23262207
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention.
Alemany L; Pérez C; Tous S; Llombart-Bosch A; Lloveras B; Lerma E; Guarch R; Andújar M; Pelayo A; Alejo M; Ordi J; Klaustermeier J; Velasco J; Guimerà N; Clavero O; Castellsagué X; Quint W; Muñoz N; Bosch FX; de Sanjosé S;
Gynecol Oncol; 2012 Mar; 124(3):512-7. PubMed ID: 22119990
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus type distribution in cervical cancer in Delhi, India.
Bhatla N; Dar L; Patro AR; Kriplani A; Gulati A; Verma K; Broor S; Shah KV; Gravitt PE
Int J Gynecol Pathol; 2006 Oct; 25(4):398-402. PubMed ID: 16990719
[TBL] [Abstract][Full Text] [Related]
4. The relationship between human papillomavirus and Epstein-Barr virus infections in relation to age of patients with cervical adenocarcinoma.
Lau HY; Twu NF; Chen PC; Lai CR; Juang CM; Yen MS; Chao KC
Taiwan J Obstet Gynecol; 2009 Dec; 48(4):370-4. PubMed ID: 20045757
[TBL] [Abstract][Full Text] [Related]
5. HPV genotyping in adenocarcinoma of the uterine cervix in Thailand.
Siriaunkgul S; Utaipat U; Suthipintawong C; Tungsinmunkong K; Triratanachat S; Khunamornpong S
Int J Gynaecol Obstet; 2013 Dec; 123(3):226-30. PubMed ID: 24095305
[TBL] [Abstract][Full Text] [Related]
6. Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery.
Lai CH; Chang CJ; Huang HJ; Hsueh S; Chao A; Yang JE; Lin CT; Huang SL; Hong JH; Chou HH; Wu TI; Huang KG; Wang CC; Chang TC
J Clin Oncol; 2007 Aug; 25(24):3628-34. PubMed ID: 17704412
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus prevalence in women with normal cytology and with cervical cancer in Natal, Brazil.
Fernandes JV; Meissner Rde V; Carvalho MG; Fernandes TA; Azevedo PR; de Azevedo JW; de Araújo JM
Mol Med Rep; 2011; 4(6):1321-6. PubMed ID: 21887467
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of human papillomavirus 16 and 18 in smears from the two cervix regions of onco-gynecological patients in Slovakia.
Kúdelová M; Krivos V; Raslová H; Valovicová M; Belvoncíková P; Matis J
Acta Virol; 2008; 52(1):17-22. PubMed ID: 18459831
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus genotyping in histological sections of precursor lesions of cervical carcinoma: its role as a possible adjunct for the evaluation of the oncogenic potential of specific human papillomavirus genotypes - a study in a coastal region of southeastern Spain.
Doménech-Peris A; Conesa-Zamora P; Sahuquillo-Frias L; Ortiz-Reina S; Moya-Biosca J; Acosta-Ortega J; Pérez-Guillermo M; Egea-Cortines M
Gynecol Obstet Invest; 2010; 70(2):113-9. PubMed ID: 20332645
[TBL] [Abstract][Full Text] [Related]
10. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
[TBL] [Abstract][Full Text] [Related]
11. Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy.
Kim JY; Park S; Nam BH; Roh JW; Lee CH; Kim YH; Shin HJ; Lee SK; Kong SY; Seong MW; Han TJ; Lee MY; Cho KH; Park SY
J Clin Oncol; 2009 Oct; 27(30):5088-93. PubMed ID: 19770372
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of Human Papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma.
Quint KD; de Koning MN; Geraets DT; Quint WG; Pirog EC
Gynecol Oncol; 2009 Sep; 114(3):390-4. PubMed ID: 19500822
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus in lung carcinomas among three Latin American countries.
Castillo A; Aguayo F; Koriyama C; Shuyama K; Akiba S; Herrera-Goepfert R; Carrascal E; Klinge G; Sánchez J; Eizuru Y
Oncol Rep; 2006 Apr; 15(4):883-8. PubMed ID: 16525675
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of human papilloma virus (HPV) genotyping and HPV-16 subtyping in vaginal carcinoma.
Larsson GL; Helenius G; Andersson S; Sorbe B; Karlsson MG
Gynecol Oncol; 2013 May; 129(2):406-11. PubMed ID: 23402906
[TBL] [Abstract][Full Text] [Related]
15. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix.
Tornesello ML; Losito S; Benincasa G; Fulciniti F; Botti G; Greggi S; Buonaguro L; Buonaguro FM
Gynecol Oncol; 2011 Apr; 121(1):32-42. PubMed ID: 21211829
[TBL] [Abstract][Full Text] [Related]
17. Type-specific human papillomavirus DNA detected in atypical glandular cell Pap tests.
Mulhem E; Amin M; Copeland J; Sharma J; Hunter S
Acta Cytol; 2012; 56(2):155-9. PubMed ID: 22378077
[TBL] [Abstract][Full Text] [Related]
18. The Prognostic Values of HPV Genotypes and Tumor PD-L1 Expression in Patients With HPV-associated Endocervical Adenocarcinoma.
Zhou F; Chen H; Li M; Strickland AL; Zheng W; Zhang X
Am J Surg Pathol; 2022 Mar; 46(3):300-308. PubMed ID: 35175967
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
20. High-risk HPV DNA testing and HPV-16/18 genotyping: what is the clinical application?
Twiggs LB; Hopkins M
J Low Genit Tract Dis; 2011 Jul; 15(3):224-30. PubMed ID: 21716051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
